SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 9th, 2016 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2016 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June _____, 2016, by and between INNOVUS PHARMACEUTICALS, INC., a Nevada corporation, with headquarters located at 9171 Towne Centre Drive, Suite 440, San Diego, CA 92122 (the “Company”), and [ ], a [ ] company, with its address [ ] (the “Buyer”).
June 24, 2016Exclusive Agency Agreement • August 9th, 2016 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2016 Company Industry Jurisdiction
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 9th, 2016 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 9th, 2016 Company IndustryThis Agreement is being entered into pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and the Buyer (the “Purchase Agreement”).
Garden State Securities Inc. Red Bank, NJ 07707Engagement Agreement • August 9th, 2016 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 9th, 2016 Company Industry JurisdictionThis letter sets forth the Agreement (the “Letter Agreement”) by and among Innovus Pharmaceuticals, Inc. and its subsidiaries and affiliates (collectively herein referred as the “Company”) and Garden State Securities Inc. and its subsidiaries and its affiliates (“GSS”) with respect to the engagement of GSS to act as a non-exclusive selling/placement agent for the Company.
FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT AND TRANSACTION DOCUMENTSSecurities Purchase Agreement • August 9th, 2016 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 9th, 2016 Company IndustryThis FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT (the “Amendment”), dated as of July [ _____], 2016, by and between INNOVUS PHARMACEUTICALS, INC., a Nevada corporation, with headquarters located at 9171 Towne Centre Drive, Suite 440, San Diego, CA 92122 (the “Company”), and [ ], a [ ] company, with its address [ ] (the “Buyer”).